NAT2 and tuberculosis: A recent meta‐analysis exploring 18 different studies on NAT2 genotype as a predictor for anti‐TB DILI is also consistent with an increased risk in slow acetylators, especially for the subgroup of slow acetylator genotypes classed as ‘ultraslow acetylators’ [45].